A randomized, placebo-controlled crossover trial of phentermine-topiramate ER in patients with binge-eating disorder and bulimia nervosa.
Debra L SaferSarah AdlerShebani Sethi DalaiJason P BentleyHannah ToyamaSarah PajaritoThomas NajarianPublished in: The International journal of eating disorders (2019)
Clinicaltrials.gov identifier NCT02553824 registered on 9/17/2015. https://clinicaltrials.gov/ct2/show/NCT02553824.
Keyphrases
- placebo controlled
- phase iii
- phase ii
- double blind
- anorexia nervosa
- study protocol
- open label
- clinical trial
- image quality
- phase ii study
- dual energy
- computed tomography
- contrast enhanced
- randomized controlled trial
- estrogen receptor
- endoplasmic reticulum
- positron emission tomography
- breast cancer cells
- magnetic resonance
- squamous cell carcinoma